[OXOLAMINE CITRATE BY THE RECTAL ROUTE IN INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT IN INFANTS. CLINICAL STUDY].
D000890:Anti-Infective Agents; D000996:Antitussive Agents; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010069:Oxadiazoles; D012137:Respiratory System; D012140:Respiratory Tract Diseases; D013488:Suppositories; D014116:Toxicology
D000890:Anti-Infective Agents; D000996:Antitussive Agents; D010069:Oxadiazoles; D013488:Suppositories; C008735:oxolamine
ANTI-INFECTIVE AGENTS; ANTITUSSIVE AGENTS; INFANT; INFANT, NEWBORN; RESPIRATORY TRACT DISEASES; SUPPOSITORIES; TOXICOLOGIC REPORT
LE CITRATE D'OXOLAMINE PAR VOIE RECTALE AU COURS DES ATTEINTES INFLAMMATOIRES DES VOIES A'ERIENNES DU NOURRISSON. ETUDE CLINIQUE.